Carlyle Group Inc. Q1 2023 Filing
Filed May 5, 2023
Portfolio Value
$3352.2T
Holdings
30
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (30 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | QDELQuidelortho Corp | 12,460,183 | $1110.1T | 33.11% | |
| 2 | GTMZoomInfo Technologies Inc | 36,662,469 | $905.9T | 27.02% | |
| 3 | MKSIMKS Instrs Inc | 8,482,732 | $751.7T | 22.43% | |
| 4 | VTRUVitru Ltd | 6,246,471 | $142.2T | 4.24% | |
| 5 | GDSGDS Hldgs Ltd | 4,072,624 | $76.0T | 2.27% | |
| 6 | PCVXVaxcyte Inc | 1,923,158 | $72.1T | 2.15% | |
| 7 | GETYGetty Images Holdings Inc | 11,902,817 | $60.6T | 1.81% | |
| 8 | VRNAVerona Pharma Plc | 2,457,500 | $49.3T | 1.47% | |
| 9 | HLVXHillevax Inc | 1,838,486 | $30.1T | 0.90% | |
| 10 | VERAVera Therapeutics Inc | 2,960,231 | $22.9T | 0.68% | |
| 11 | PHATPhathom Pharmaceuticals Inc | 2,935,106 | $20.9T | 0.62% | |
| 12 | JSPRJasper Therapeutics Inc | 8,761,891 | $15.8T | 0.47% | |
| 13 | INVHInvitation Homes Inc | 477,500 | $14.9T | 0.44% | |
| 14 | OKURReneo Pharmaceuticals Inc | 2,073,957 | $12.2T | 0.37% | |
| 15 | TORCEURAdicet Bio Inc | 2,115,385 | $12.2T | 0.36% | |
| 16 | SSS1EURLife Storage Inc | 86,000 | $11.3T | 0.34% | |
| 17 | CUBECubeSmart | 220,500 | $10.2T | 0.30% | |
| 18 | SMHISeacor Marine Hldgs Inc | 1,314,043 | $10.0T | 0.30% | |
| 19 | SPRBSpruce Biosciences Inc | 2,896,518 | $6.4T | 0.19% | |
| 20 | EMSmart Sh Global Ltd | 4,810,209 | $5.3T | 0.16% | |
| 21 | —Nucana Plc | 3,333,333 | $3.2T | 0.10% | |
| 22 | —Paratek Pharmaceuticals Inc | 1,041,131 | $2.6T | 0.08% | |
| 23 | SLNOSoleno Therapeutics Inc | 1,201,506 | $2.5T | 0.08% | |
| 24 | EFTREffector Therapeutics Inc | 4,822,114 | $1.7T | 0.05% | |
| 25 | CBAYUSDCymabay Therapeutics Inc | 131,036 | $1.1T | 0.03% | |
| 26 | —Meta Data Limited | 314,400 | $329.3B | 0.01% | |
| 27 | SIENSientra Inc | 167,358 | $256.1B | 0.01% | |
| 28 | XCUREURExicure Inc | 281,636 | $242.2B | 0.01% | |
| 29 | —Molecular Templates Inc | 200,000 | $75.0B | 0.00% | |
| 30 | AGLEUSDAeglea Biotherapeutics Inc | 240,500 | $69.0B | 0.00% |